Boehringer Ingelheim brand of telmisartan

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

162 API Suppliers, 40 USDMF, 44 CEP/COS, 18 JDMF, 29 EU WC, 48 KDMF, 21 NDC API, 74 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

136 Drugs in Development

136 Drugs in Development

INTERMEDIATES

53 Intermediate Suppliers

53 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

954 FDF Dossiers, 113 FDA Orange Book, 410 Europe, 62 Canada, 28 Australia, 73 South Africa, 268 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG, TABLET;ORAL - 40MG, TABLET;ORAL - 80MG, TABLET;ORAL - 12.5MG;40MG, TABLET;ORAL - 12.5MG;80MG, TABLET;ORAL - 25MG;80MG, TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Rochem International Inc, 19 SPI Pharma, 4 DKSH, 8 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 1 ACG Worldwide, 1 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 14 BASF, 1 CD Formulation, 10 Corel Pharma Chem, 7 DFE Pharma, 8 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

73 Fillers, Diluents & Binders, 44 Disintegrants & Superdisintegrants, 41 Direct Compression, 40 Coating Systems & Additives, 31 Granulation, 22 Chewable & Orodispersible Aids, 21 Lubricants & Glidants, 19 Taste Masking, 18 Controlled & Modified Release, 18 Thickeners and Stabilizers, 14 Co-Processed Excipients, 14 Film Formers & Plasticizers, 11 Solubilizers, 9 Parenteral, 5 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 5 Emulsifying Agents, 4 Vegetarian Capsules, 3 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

44 News #PharmaBuzz

44 News #PharmaBuzz

GLOBAL SALES INFORMATION

20 US Medicaid Prescriptions, 372 Regulatory FDF Prices, 7 Annual Reports

MARKET PLACE

35 APIs, 12 FDF Dossiers

PATENTS & EXCLUSIVITIES

28 Health Canada Patents

28 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 17 Others

ANALYTICAL

2 BioAnalytical Methods, 2 Analytical Methods

$ Xls

Filters

Digital Content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

Piramal Pharma Backs George Medicines in Hypertension Drug

29 Aug 2025

// PR NEWSWIRE

George Medicine, Azurity Pharma Ink Deal to Market WIDAPLIK in US

21 Jul 2025

// GLOBENEWSWIRE

Veristat Congratulate George Medicine on FDA Approval of Widaplik

16 Jun 2025

// BUSINESSWIRE

George Medicines announces FDA approval of Widaplik

09 Jun 2025

// GLOBENEWSWIRE

Maharashtra FDA begins probe stickering & mislabelling on Glenmark's drug Telma

05 Apr 2024

// DERUG CONTROL

Enforcement Report - Week of August 17, 2022

17 Aug 2022

// FDA

Boehringer Ingelheim Brand Of Telmisartan

Boehringer Ingelheim brand of telmisartan

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

162 API Suppliers

40 USDMF

44 CEP/COS

18 JDMF

29 EU WC

48 KDMF

21 NDC API

74 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

136 Drugs in Development

INTERMEDIATES

53 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

954 FDF Dossiers

113 FDA Orange Book

410 Europe

62 Canada

28 Australia

73 South Africa

268 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 20MG

TABLET;ORAL - 40MG

TABLET;ORAL - 80MG

TABLET;ORAL - 12.5MG;40MG

TABLET;ORAL - 12.5MG;80MG

TABLET;ORAL - 25MG;80MG

TABLET;ORAL - EQ 10MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 10MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 5MG BASE;80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

2 Rochem International Inc

19 SPI Pharma

4 DKSH

8 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

1 ACG Worldwide

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

14 BASF

1 CD Formulation

10 Corel Pharma Chem

7 DFE Pharma

8 Gangwal Chemicals

4 Ideal Cures

5 Ingredion Pharma Solutions

24 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

15 Microlex e.U

3 Nitika Pharmaceutical Specialities

3 Novo Excipients

5 Pharmatrans-Sanaq

6 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

29 Roquette

7 Seppic

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

4 Silverline Chemicals

TABLET;ORAL - EQ 10MG BASE;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 10MG BASE;80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 5MG BASE;80MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons